Countdown to 2022 CBIIC：
Executive President of PhIRDA
Mr. Song Ruilin is the Executive President of China Pharmaceutical Innovation and Research Development Association (PhIRDA), Expert of the Talent Pool for State Affairs of Chinese People's Political Consultative Conference (CPPCC) and Expert for State Affairs of Central Committee of Chinese Peasants and Workers Democratic Party. He is also L.L.B. of China University of Political Science and Law, EMBA of China Europe International Business School, Doctor of Social and Administrative Pharmacy of China Pharmaceutical University and Visiting Scholar of the University of Sydney. Mr. Song had served in the Legislative Affairs Office at State Council of China for a long time, engaging in health and drug policy, legal studies and in charge of law making and reviewing in the areas of pharmaceutical and healthcare industry. He has made great contribution in optimizing the reform of drug review and approval system, medical insurance reimbursement system and making policies for pharmaceutical innovation in China. Currently, Mr. Song also undertakes several social positions, such as Executive Deputy Director of the Research Center of National Drug Policy & Ecosystem of China Pharmaceutical University, Guest Research Professor of Shanghai Jiao Tong University,Biotech Advisory Panel Member of the Stock Exchange of Hong Kong Limited, the Vice President of China Alliance for Rare Disease (CARD), Director of Chinese Pharmaceutical Association (CPA), Director of Chinese Pharmacists Association and Director of Bethune Charitable Foundation .